Skip to content

High prevalence of vitamin D deficiency in patients with HIV

Abacavir treatment doesn't cause changes in biomarkers linked to heart attack, suggests small study

Rare abacavir liver side-effects reported

Continued antiretroviral therapy reduces bone mineral density in SMART study

Ezetimibe safe and effective for cholesterol reduction in patients taking HIV treatment

Switching to AZT from d4T poses challenges in resource-limited settings

Low CD4 cell count, but not HIV treatment, increases risk of hardening of the arteries

Long-term HIV treatment cuts risk of hardening of coronary artery

Heat-stable ritonavir tablet equivalent to soft gel capsule; may be approved next year